Thursday, July 9, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “VISTAGEN THERAPUETICS, INC.”

6 pharma patents match "VISTAGEN THERAPUETICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "VISTAGEN THERAPUETICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “VISTAGEN THERAPUETICS, INC.” · 30,257 patents in full index Clear search

  1. US 12036198

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted

  2. US 10980758

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  3. US 10632091

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  4. US 10617663

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  5. US 9993453

    Dosage forms and therapeutic uses L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

  6. US 9993450

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.